🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, company-sponsored, non-interventional cohort s...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00905684
Treatments Being Tested
This study will investigate the potential drug interactions between vemirco...
Status
Completed
Location
Research Site
Start Date
2024-01-17
Trial ID
NCT06071442
Treatments Being Tested
The purpose of this study is to evaluate the effect of CC-99677 coadministr...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2020-09-30
Trial ID
NCT04718636
Treatments Being Tested
The purpose of this study is to evaluate the effect of JNJ-64530440 single-...
Status
Withdrawn
Location
PRA Health Sciences
Start Date
2021-06-01
Trial ID
NCT03890341
Treatments Being Tested
The purpose of this study is to estimate the effect of filibuvir on the pha...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT00918476
Treatments Being Tested
The risk of venous thromboembolism (VTE) associated with the use of chlorma...
Status
Completed
Location
Center for Epidemiology and Health Research Berlin
Start Date
2022-03-10
Trial ID
NCT02828904
The purpose of the study is to evaluate the effectiveness of the study drug...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00566384
Treatments Being Tested
EURAS is a multi-national, controlled, prospective, post-marketing, non-int...
Status
Completed
Location
Center for Epidemiology and Health Research
Start Date
2000-11
Trial ID
NCT00302848
Treatments Being Tested
The objectives of this study were to evaluate the efficacy and safety of dr...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00656981
Treatments Being Tested
This is a Phase 1, fixed sequence, multiple dose, open label study of the e...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2019-10-23
Trial ID
NCT04134715
Treatments Being Tested